{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T23:31:05Z","timestamp":1783812665630,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Concentric left ventricular hypertrophy (cLVH) is a common left ventricular geometric pattern in patients undergoing maintenance dialysis, including peritoneal dialysis (PD). The relationship between cLVH at PD initiation and the prognosis of patients remains unclear, however. This study aimed to investigate the impact of cLVH at PD initiation on patient survival and major adverse cardiovascular events (MACE).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The retrospective cohort study included 131 patients who underwent echocardiography during the PD initiation period. Based on echocardiographic measurements, cLVH was defined as a condition with increased LV mass index and increased relative wall thickness. The relationship between cLVH and the prognosis was assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Concentric LVH was identified in 29 patients (22%) at PD initiation, and patient survival, MACE-free survival and PD continuation were significantly reduced in the cLVH group compared with the non-cLVH group. In the Cox regression analysis, cLVH was demonstrated as an independent risk factor of mortality (HR [95%CI]: 3.32 [1.13\u20139.70]) for all patients. For patients over 65\u2009years old, cLVH was significantly associated with mortality and MACE (HR [95%CI]: 3.51 [1.06\u201311.58] and 2.97 [1.26\u20137.01], respectively). Serum albumin at PD initiation was independently correlated with cLVH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In our study, cLVH at PD initiation was independently associated with survival in all patients and with both survival and MACE in elderly patients. Evaluation of LV geometry at PD initiation might therefore help identify high-risk patients. Further studies involving larger numbers of patients are needed to confirm the findings from this study and clarify whether treatment interventions for factors such as nutrition status could ameliorate cLVH and improve patient outcomes.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12882-021-02321-1","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T18:03:21Z","timestamp":1618596201000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Prognostic significance of concentric left ventricular hypertrophy at peritoneal dialysis initiation"],"prefix":"10.1186","volume":"22","author":[{"given":"Misato","family":"Tomura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Hamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Komaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Kume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaomi","family":"Nangaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,16]]},"reference":[{"issue":"3","key":"2321_CR1","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1053\/j.ajkd.2019.01.001","volume":"73","author":"R Saran","year":"2019","unstructured":"Saran R, Robinson B, Abbott KC, Agodoa LYC, Bragg-Gresham J, Balkrishnan R, et al. US renal data system 2018 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2019;73(3):A7\u20138. https:\/\/doi.org\/10.1053\/j.ajkd.2019.01.001.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"2321_CR2","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1097\/01.ASN.0000135053.98172.D6","volume":"15","author":"AY Wang","year":"2004","unstructured":"Wang AY, Wang M, Woo J, Lam CW, Lui S, Li PK, et al. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal Dialysis patients. J Am Soc Nephrol. 2004;15(8):2186\u201394. https:\/\/doi.org\/10.1097\/01.ASN.0000135053.98172.D6.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2321_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/ki.1995.22","volume":"47","author":"RN Foley","year":"1995","unstructured":"Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47(1):186\u201392. https:\/\/doi.org\/10.1038\/ki.1995.22.","journal-title":"Kidney Int"},{"issue":"10","key":"2321_CR4","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1681\/ASN.V11101948","volume":"11","author":"SG Rostand","year":"2000","unstructured":"Rostand SG. Coronary heart disease in chronic renal insufficiency: some management considerations. J Am Soc Nephrol. 2000;11(10):1948\u201356.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2321_CR5","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/S0272-6386(00)70239-3","volume":"35","author":"MJ Sarnak","year":"2000","unstructured":"Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis. 2000;35(4):S117\u201331. https:\/\/doi.org\/10.1016\/S0272-6386(00)70239-3.","journal-title":"Am J Kidney Dis"},{"issue":"5 Suppl 3","key":"2321_CR6","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"RN Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112\u20139. https:\/\/doi.org\/10.1053\/ajkd.1998.v32.pm9820470.","journal-title":"Am J Kidney Dis"},{"issue":"14","key":"2321_CR7","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1056\/NEJM199210013271406","volume":"327","author":"ED Frohlich","year":"1992","unstructured":"Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, et al. The heart in hypertension. N Engl J Med. 1992;327(14):998\u20131008. https:\/\/doi.org\/10.1056\/NEJM199210013271406.","journal-title":"N Engl J Med"},{"issue":"4","key":"2321_CR8","first-page":"217","volume":"10","author":"M Cafka","year":"2016","unstructured":"Cafka M, Rroji M, Seferi S, Barbullushi M, Burazeri G, Spahia N, et al. Inflammation, left ventricular hypertrophy, and mortality in end-stage renal disease. Iran J Kidney Dis. 2016;10(4):217\u201323.","journal-title":"Iran J Kidney Dis"},{"issue":"10","key":"2321_CR9","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1097\/01.ASN.0000088724.66957.FC","volume":"14","author":"G de Simone","year":"2003","unstructured":"de Simone G. Left ventricular geometry and hypotension in end-stage renal disease: a mechanical perspective. J Am Soc Nephrol. 2003;14(10):2421\u20137. https:\/\/doi.org\/10.1097\/01.ASN.0000088724.66957.FC.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2321_CR10","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/0735-1097(94)00473-4","volume":"25","author":"HM Krumholz","year":"1995","unstructured":"Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham heart study. J Am Coll Cardiol. 1995;25(4):879\u201384. https:\/\/doi.org\/10.1016\/0735-1097(94)00473-4.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2321_CR11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/089686080002000414","volume":"20","author":"S Silaruks","year":"2000","unstructured":"Silaruks S, Sirivongs D, Chunlertrith D. Left ventricular hypertrophy and clinical outcome in CAPD patients. Perit Dial Int. 2000;20(4):461\u20136. https:\/\/doi.org\/10.1177\/089686080002000414.","journal-title":"Perit Dial Int"},{"issue":"7","key":"2321_CR12","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.echo.2015.05.002","volume":"28","author":"TH Marwick","year":"2015","unstructured":"Marwick TH, Gillebert TC, Aurigemma G, Chirinos J, Derumeaux G, Galderisi M, et al. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). J Am Soc Echocardiogr. 2015;28(7):727\u201354. https:\/\/doi.org\/10.1016\/j.echo.2015.05.002.","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"2321_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1536\/ihj.14-246","volume":"56","author":"K Hassan","year":"2015","unstructured":"Hassan K, Hassan S, Anwar S, Zaher A, Edgem R, Hassan F. Predictors of left ventricular hypertrophy and their cutoffs in peritoneal dialysis patients. Int Heart J. 2015;56(2):186\u201391. https:\/\/doi.org\/10.1536\/ihj.14-246.","journal-title":"Int Heart J"},{"key":"2321_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1159\/000336946","volume":"35","author":"M Yilmaz","year":"2013","unstructured":"Yilmaz M, Unsal A, Oztekin E, Kesmezacar O, Harmankaya Kaptanogullari O, Eren N. The prevalence of hypertension, valve calcification and left ventricular hypertrophy and geometry in peritoneal dialysis patients. Kidney Blood Press Res. 2013;35:431\u20137.","journal-title":"Kidney Blood Press Res."},{"issue":"4","key":"2321_CR15","first-page":"482","volume":"27","author":"A Rosell\u00f3","year":"2007","unstructured":"Rosell\u00f3 A, Torregrosa I, Sol\u00eds MA, Mu\u00f1oz J, Pascual B, Garc\u00eda R, et al. Study of diastolic function in peritoneal dialysis patientes. Comparison between pulsed and Tissue Doppler. Nefrologia. 2007;27(4):482\u20138. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17944586.","journal-title":"Nefrologia."},{"issue":"6","key":"2321_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1159\/000336946","volume":"35","author":"M Yilmaz","year":"2012","unstructured":"Yilmaz M, Unsal A, Oztekin E, Kesmezacar O, Harmankaya Kaptanogullari O, Eren N. The prevalence of hypertension, valve calcification and left ventricular hypertrophy and geometry in peritoneal Dialysis patients. Kidney Blood Press Res. 2012;35(6):431\u20137. https:\/\/doi.org\/10.1159\/000336946.","journal-title":"Kidney Blood Press Res"},{"issue":"5","key":"2321_CR17","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/08037051.2017.1306422","volume":"26","author":"A Toba","year":"2017","unstructured":"Toba A, Kariya T, Aoyama R, Ishiyama T, Tsuboko Y, Takeda K, et al. Impact of age on left ventricular geometry and diastolic function in elderly patients with treated hypertension. Blood Press. 2017;26(5):264\u201371. https:\/\/doi.org\/10.1080\/08037051.2017.1306422.","journal-title":"Blood Press"},{"issue":"2","key":"2321_CR18","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1161\/01.CIR.0000048893.62841.F7","volume":"107","author":"EG Lakatta","year":"2003","unstructured":"Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease. Circulation. 2003;107(2):346\u201354. https:\/\/doi.org\/10.1161\/01.CIR.0000048893.62841.F7.","journal-title":"Circulation."},{"issue":"1","key":"2321_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/ndt\/13.1.17","volume":"13","author":"GM London","year":"1998","unstructured":"London GM. Heterogeneity of left ventricular hypertrophy--does it have clinical implications? Nephrol Dial Transplant. 1998;13(1):17\u20139. https:\/\/doi.org\/10.1093\/ndt\/13.1.17.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"2321_CR20","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1161\/01.RES.67.4.871","volume":"67","author":"P Anversa","year":"1990","unstructured":"Anversa P, Palackal T, Sonnenblick EH, Olivetti G, Meggs LG, Capasso JM. Myocyte cell loss and Myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res. 1990;67(4):871\u201385. https:\/\/doi.org\/10.1161\/01.RES.67.4.871.","journal-title":"Circ Res"},{"issue":"6","key":"2321_CR21","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1161\/01.RES.68.6.1560","volume":"68","author":"G Olivetti","year":"1991","unstructured":"Olivetti G, Melissari M, Capasso JM, Anversa P. Cardiomyopathy of the aging human heart Myocyte loss and reactive cellular hypertrophy. Circ Res. 1991;68(6):1560\u20138. https:\/\/doi.org\/10.1161\/01.RES.68.6.1560.","journal-title":"Circ Res"},{"issue":"1","key":"2321_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000113503","volume":"54","author":"D Bernhard","year":"2008","unstructured":"Bernhard D, Laufer G. The aging Cardiomyocyte: a mini-review. Gerontology. 2008;54(1):24\u201331. https:\/\/doi.org\/10.1159\/000113503.","journal-title":"Gerontology."},{"issue":"5","key":"2321_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10741-010-9173-7","volume":"15","author":"LSM Wong","year":"2010","unstructured":"Wong LSM, van der Harst P, de Boer RA, Huzen J, Van Gilst WH, Van Veldhuisen DJ. Aging, telomeres and heart failure. Heart Fail Rev. 2010;15(5):479\u201386. https:\/\/doi.org\/10.1007\/s10741-010-9173-7.","journal-title":"Heart Fail Rev"},{"issue":"4","key":"2321_CR24","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/j.1523-1755.2004.00525.x","volume":"65","author":"MM Mitsnefes","year":"2004","unstructured":"Mitsnefes MM, Kimball TR, Border WL, Witt SA, Glascock BJ, Khoury PR, et al. Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int. 2004;65(4):1461\u20136. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00525.x.","journal-title":"Kidney Int"},{"issue":"10-11","key":"2321_CR25","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1007\/s004670000303","volume":"14","author":"MM Mitsnefes","year":"2000","unstructured":"Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife CF. Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol. 2000;14(10-11):898\u2013902. https:\/\/doi.org\/10.1007\/s004670000303.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"2321_CR26","doi-asserted-by":"publisher","first-page":"e0124772","DOI":"10.1371\/journal.pone.0124772","volume":"10","author":"J Gupta","year":"2015","unstructured":"Gupta J, Dominic EA, Fink JC, Ojo AO, Barrows IR, Reilly MP, et al. Association between inflammation and cardiac geometry in chronic kidney disease: findings from the CRIC study. PLoS One. 2015;10(4):e0124772. https:\/\/doi.org\/10.1371\/journal.pone.0124772.","journal-title":"PLoS One"},{"key":"2321_CR27","doi-asserted-by":"crossref","unstructured":"Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol. 1996;7(5):728-36.","DOI":"10.1681\/ASN.V75728"},{"issue":"2","key":"2321_CR28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.4269\/ajtmh.1971.20.343","volume":"20","author":"J Piza","year":"1971","unstructured":"Piza J, Troper L, Cespedes R, Miller JH, Berensoni AS. Myocardial lesions and heart failure in infantile malnutrition. Am J Trop Med Hyg. 1971;20(2):343\u201355. https:\/\/doi.org\/10.4269\/ajtmh.1971.20.343.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"2321_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1053\/j.ajkd.2019.02.013","volume":"74","author":"K Izumaru","year":"2019","unstructured":"Izumaru K, Hata J, Nakano T, Nakashima Y, Nagata M, Fukuhara M, et al. Reduced estimated GFR and cardiac remodeling: a population-based autopsy study. Am J Kidney Dis. 2019;74(3):373\u201381. https:\/\/doi.org\/10.1053\/j.ajkd.2019.02.013.","journal-title":"Am J Kidney Dis"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02321-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-021-02321-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02321-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T23:17:47Z","timestamp":1619911067000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02321-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,16]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2321"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02321-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,16]]},"assertion":[{"value":"1 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the University of Tokyo (#2879). As this study retrospectively collected the data from medical records, written consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}